10-Deacetyl Baccatin III (CAS 32981-86-5) is a superior Pharmaceutical Grade Compound employed in the synthesis of the life-saving anti-cancer drug Paclitaxel (Taxol). Mostly derived from Taxus Wallichina and Taxus Baccata, this pharmaceutical compound, characterized as a white-to-off-white crystalline powder, imparts excellent solubility in organic solvents. Key factors to consider:
10-Deacetyl Baccatin III (CAS Number 32981-86-5), colloquially known as 10-DAB III, is a potent natural compound that plays a pivotal role in cancer research and treatment. Extracted from the Taxus Wallichina and Taxus Baccata plants, this element is an integral part of paclitaxel production, a crucial drug in modern cancer therapeutics.
With a natural origin, 10-DAB III is a reliable and highly trusted component within the medical industry. Its pharmaceutical grade compliance ensures its suitability and dependability within laboratory environments and demanding medical scenarios. In addition, its fast dispatch feature makes it highly adaptable to your project timelines.
One of the defining roles of 10-DAB III is its significant contribution to the production of Paclitaxel, a leading player within cancer have therapeutic approaches. With broad applications in robust medical settings, this compound has become an essential tool in revolutionizing the field of oncology. However, due to its potential health impacts and the precision of its usage, it is best confined to pharmaceutical-grade scenarios. Users are strongly advised to exercise extreme caution and follow recommended safety measures during handling and use.
Considering the hazardous potential of 10-DAB III, it is recommended to handle this compound in a controlled environment, following strict safety measures. Appropriate personal protective equipment should be worn at all times and exposure should be minimized as much as possible to ensure user safety.